Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00004048
What this trial is testing

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 30
Not applicableStudy completedNCT00898391
What this trial is testing

Study of DNA in Blood Samples From Patients With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 329
Not applicableStudy completedNCT01776125
What this trial is testing

Genetic Evaluation of NF1 and Scoliosis Patients

Who this might be right for
Neurofibromatosis 1Scoliosis
University of Minnesota 59
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableLooking for participantsNCT07516678
What this trial is testing

Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Testing effectiveness (Phase 2)WithdrawnNCT01048086
What this trial is testing

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Who this might be right for
NeuroblastomaNeuroendocrine Tumor
University of Iowa
Large-scale testing (Phase 3)Study completedNCT00002802
What this trial is testing

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Hospital Medical Center, Cincinnati 500
Early research (Phase 1)Study completedNCT04730583
What this trial is testing

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibroma
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00634270
What this trial is testing

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1
University of Alabama at Birmingham 58
Not applicableLooking for participantsNCT05904340
What this trial is testing

Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

Who this might be right for
Breast NeoplasmsChemotherapy-induced Peripheral Neuropathy
National Taipei University of Nursing and Health Sciences 86
Not applicableLooking for participantsNCT06222203
What this trial is testing

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Who this might be right for
Neurofibromatosis 1Nerve Sheath Neoplasms
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04917042
What this trial is testing

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Peripheral Nerve Sheath Tumor
University of Florida 10
Large-scale testing (Phase 3)Study completedNCT00659269
What this trial is testing

Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

Who this might be right for
Cancer
New Mexico Cancer Research Alliance 319
Early research (Phase 1)Looking for participantsNCT07358260
What this trial is testing

B7-H3.CD28Z.CART in Solid Tumors

Who this might be right for
Pediatric Solid TumorNeuroblastoma
Robbie Majzner 40
Early research (Phase 1)Ended earlyNCT02536183
What this trial is testing

A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

Who this might be right for
Pediatric CancerSolid TumorsRhabdomyosarcoma+7 more
AeRang Kim 2
Large-scale testing (Phase 3)UnknownNCT00276731
What this trial is testing

Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Large-scale testing (Phase 3)Active Not RecruitingNCT05913037
What this trial is testing

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT03363373
What this trial is testing

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics 122
Next Page